Yamanaka K - Search Results

1

Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks.

Kondo M, Matsushima Y, Nakanishi T, Iida S, Koji H, Yamanaka K. Kondo M, et al. Among authors: yamanaka k. Clin Pract. 2023 Feb 6;13(1):246-250. doi: 10.3390/clinpract13010022. Clin Pract. 2023. PMID: 36826164 Free PMC article.

2

Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection.

Kondo M, Kurokawa I, Ito Y, Yamanaka K, Yamazaki T, Mizutani H. Kondo M, et al. Among authors: yamanaka k. Int J Dermatol. 2009 Dec;48(12):1330-3. doi: 10.1111/j.1365-4632.2008.04060.x. Int J Dermatol. 2009. PMID: 20415674

3

Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus?

Kondo M, Kurokawa I, Yamanaka K, Akachi S, Nishii M. Kondo M, et al. Among authors: yamanaka k. Int J Dermatol. 2010 Dec;49(12):1403-5. doi: 10.1111/j.1365-4632.2010.04584.x. Int J Dermatol. 2010. PMID: 21091673

4

Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses.

Tsuda K, Yamanaka K, Linan W, Miyahara Y, Akeda T, Nakanishi T, Kitagawa H, Kakeda M, Kurokawa I, Shiku H, Gabazza EC, Mizutani H. Tsuda K, et al. Among authors: yamanaka k. PLoS One. 2011;6(12):e29020. doi: 10.1371/journal.pone.0029020. Epub 2011 Dec 21. PLoS One. 2011. PMID: 22216160 Free PMC article.

5

Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells.

Tsuda K, Yamanaka K, Kitagawa H, Akeda T, Naka M, Niwa K, Nakanishi T, Kakeda M, Gabazza EC, Mizutani H. Tsuda K, et al. Among authors: yamanaka k. PLoS One. 2012;7(2):e31465. doi: 10.1371/journal.pone.0031465. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359594 Free PMC article.

6

Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation.

Nakanishi T, Yamanaka K, Kakeda M, Tsuda K, Mizutani H. Nakanishi T, et al. Among authors: yamanaka k. Arch Dermatol Res. 2013 Apr;305(3):241-7. doi: 10.1007/s00403-012-1302-9. Epub 2012 Nov 21. Arch Dermatol Res. 2013. PMID: 23179586

7

Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity.

Tsuda K, Yamanaka K, Kondo M, Matsubara K, Sasaki R, Tomimoto H, Gabazza EC, Mizutani H. Tsuda K, et al. Among authors: yamanaka k. PLoS One. 2012;7(12):e51819. doi: 10.1371/journal.pone.0051819. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251632 Free PMC article.

8

Continuous high-dose antigen exposure preferentially induces IL-10, but intermittent antigen exposure induces IL-4.

Yamanaka K, Nakanishi T, Watanabe J, Kondo M, Yamagiwa A, Gabazza EC, Mizutani H. Yamanaka K, et al. Exp Dermatol. 2014 Jan;23(1):63-5. doi: 10.1111/exd.12295. Exp Dermatol. 2014. PMID: 24299227

9

Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils.

Yamanaka K, Umezawa Y, Yamagiwa A, Saeki H, Kondo M, Gabazza EC, Nakagawa H, Mizutani H. Yamanaka K, et al. J Dermatol. 2014 Aug;41(8):679-85. doi: 10.1111/1346-8138.12560. J Dermatol. 2014. PMID: 25099154 Clinical Trial.

10

Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases.

Yamanaka K, Nakanishi T, Saito H, Maruyama J, Isoda K, Yokochi A, Imanaka-Yoshida K, Tsuda K, Kakeda M, Okamoto R, Fujita S, Iwakura Y, Suzuki N, Ito M, Maruyama K, Gabazza EC, Yoshida T, Shimaoka M, Mizutani H. Yamanaka K, et al. PLoS One. 2014 Aug 13;9(8):e104479. doi: 10.1371/journal.pone.0104479. eCollection 2014. PLoS One. 2014. PMID: 25119884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,689 results

Search Page